Primary record
6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one 2-hydroxy-ethanesulfonic acid (1:1)
- 库存
- 5,737 克
- 纯度
- 98.4 %
- CAS
- 439081-18-2
化合物标识与属性
- CAS
- 439081-18-2
- PubChem CID
- 10184653
- SMILES
- CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4
- Canonical SMILES
- CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1
名称与同义词
- Afatinib
- Tovok
- Tomtovok
- BIBW2992
- 439081-18-2
- 850140-72-6
- afatinibum
- BIBW 2992
- Gilotrif
- (E/Z)-Afatinib
- Afatinib maleate
- Afatinib free base
- Afatinib, Free Base
- BIBW-2992
- Afatinib [USAN]
- Afatinib (BIBW2992)
- Afatinib E-Isomer
- (S)-Afatinib
- Tovok,BIBW2992
- BIBW2992 (Tovok)
- C24H25ClFN5O3
- Tovok (TN)
- Afatinib [USAN:INN]
- BIBW2992 Afatinib
- BIBW2992,Afatinib
- RefChem:56995
- Afatinib (USAN/INN)
- AFATINIB [INN]
- AFATINIB [MI]
- AFATINIB DIMALEATE
- Tovok, BIBW2992
- AFATINIB [VANDF]
- EGFR inhibitor 2nd gens
- GlyTouCan:G02851FW
- AFATINIB [MART.]
- BIBW2992 - Afatinib
- MFCD12407405
- AFATINIB [WHO-DD]
- D05UFG
- UNII-41UD74L59M
- 41UD74L59M
- Tovok|||BIBW 2992
- CHEMBL1173655
- (E/Z)-Afatinib (Standard)
- Afatinib - Bio-X trade mark
- cc-109
- CHEBI:61390
- MLS006010000
- orb322739
- NSC-750691
- SCHEMBL232772
- DTXSID20893451
- EX-A065A
- GTPL5667
- orb1306404
- SCHEMBL29388685
- SCHEMBL29395096
- BIBW-2929
- CHEBI:94698
- 850140-72-6 (free base)
- EX-A065
- L01XE13
- QCR-169
- NSC750691
- ULXXDDBFHOBEHA-CWDCEQMOSA-N
- (S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- BCPP000338
- BIBW 29 92
- DTXCID301323466
- GLXC-21899
- GLXC-90096
- HY-10261BR
- Afatinib, 99% - 25MG 25mg
- AMX10177
- AOB87785
- BCP01779
- G02851FW
- ZINC3976838
- BIBW2992/Tovok,BIBW-2992
- 3123AC
- ABP000859
- AN-537
- BDBM50322823
- EBC-12394
- HY-10261B
- MFCD31630115
- MSK162749
- NSC799327
- Afatinib(cis-trans isomerismtautomers)
- AKOS015850681
- AKOS015904219
- AKOS025149636
- ACN-036294
- BCP9000407
- CCG-264776
- DB08916
- EX-8656
- FC17230
- NSC-799327
- RL05240
- SDCCGSBI-0654325.P001
- CID10184653
- NCGC00185000-01
- NCGC00185000-22
- NCGC00185000-23
- S1011
- AC-26079
- AC-27018
- AJ-47553
- AM808098
- AS-80916
- BA164141
- BP-43626
- CID 10184653
- DS-14172
- SC-66830
- SC-87772
- SMR004701084
- SY028094
- SY047316
- AB0033685
- N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-Butenamide
- PD0332991
- TC-162525
- TC-163608
- A2870
- A8247
- CS-0020030
- FT-0651456
- FT-0661434
- NS00077621
- ST24036355
- SW219248-1
- X7366
- (S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- J2.685.397D
- J3.363.130H
- A10141
- A15572
- D09724
- Q-3651
- AB01565886_02
- EN300-6487482
- 081B182
- A850102
- EN300-19625328
- F050665
- SR-01000941576
- (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- (E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
- Q4688818
- SR-01000941576-1
- 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino
- BRD-K66175015-001-01-7
- BRD-K66175015-001-09-0
- BRD-K66175015-001-13-2
- BRD-K66175015-332-01-6
- I14-17009
- (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide
- Z2568727518
- B0084-092426
- B0084-258486
- (E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide
- (S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide.
- (S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-
- N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-oxolan-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- (2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3s)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-2-butenamide
- (2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((3S)-oxolan-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- (2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((3S)-tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- (2E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[[(3S)-oxolane-3-yl]oxy]quinazoline-6-yl]-4-(dimethylamino)-2-buteneamide
- (2E)-N-[4-(3-Chloro-4-fluoroanilino)-7-{[(3S)-oxolan-3-yl]oxy}quinazolin-6-yl]-4-(dimethylamino)but-2-enamide
- (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
- (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide; BIBW 2992;
- (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydrofuran-3-yl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-buteneamide
- (E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl)-amide
- (E)-4-dimethylamino-but-2-enoic acid-(4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6yl)-amide
- (E)-4-Dimethylamino-but-2-enoic acid-[4-(3-chloro-4-fluoro-phenylamino)-7-((S)-tetrahydrofuran-3-yloxy)-quinazolin-6-yl]-amide
- (E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydrofuran-3-yl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
- (S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- (S)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[(3-tetrahydrofuranyl)oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
- 0WM
- 1254955-21-9
- 2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-
- 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-
- 2-BUTENAMIDE, N-[4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-7-[[(3S)-TETRAHYDRO-3-FURANYL]OXY]-6-QUINAZOLINYL]-4-(DIMETHYLAMINO)-
- 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-
- 2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-
- 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one 2-hydroxy-ethanesulfonic acid (1:1)
- 810-720-4
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3''S'')-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4(dimethylamino)-2-butenamide
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4(dimethylamino)-2-butenamide
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydrofuran-3-yl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-buteneamide